We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Agronomics Limited | LSE:ANIC | London | Ordinary Share | IM00B6QH1J21 | ORD 0.0001P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.03 | 0.39% | 7.78 | 7.70 | 7.90 | 7.80 | 7.75 | 7.75 | 3,077,080 | 16:35:19 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Investors, Nec | 30.88M | 22.37M | 0.0222 | 3.51 | 78.73M |
TIDMANIC
RNS Number : 4650J
Agronomics Limited
14 April 2020
14 April 2020
Agronomics Limited
(the "Company")
Net Asset Value calculation to 31 March 2020
Richard Reed, Chairman, commented: -
"The Net Asset Value ("NAV") calculation for the Company as at closing on 31 March 2020 was 5.53 pence per share, including un-invested cash of GBP3,890,306. The portfolio is valued under IFRS at bid price. The share price of 5.25 pence at the 31 March 2020 close represents a discount of 5% to the NAV. Net Assets stand at GBP18.3 million, including investments of GBP14.5 million. This quarter's NAV per share represents an increase of 5% from the previous quarters NAV of 5.26 pence per share, which included un-invested cash of GBP4,669,881. No management fee is due to Shellbay Investments Limited.
During January 2020, the Company completed an additional fundraise, raising net proceeds of GBP5.2m. Total gross funds raised during the 2020 financial year now stand at GBP17.6 million. Existing funds will be deployed in line with the new investment policy.
On 12 February 2020, the Company invested US$ 3 million into Foods United, Inc ("Foods United"). This was part of a US$ 100 million fundraise by Foods United, which was founded by Blue Horizon Corporation, a major early player in the alternative protein sector with an established portfolio of 39 seed investments.
The Company completed a further US$ 1 million SAFE investment into VitroLabs, Inc ("Vitro") on 13 February 2020. Upon conversion into equity, this will equate to an estimated 6.15% equity interest in Vitro.
On 27 February 2020, the Company announced that BlueNalu, Inc completed its US$ 20 million Series A funding round, with participation from major strategic investors with expertise across operations, sales, marketing, distribution and supply chain structuring.
On 10 March 2020, the Company completed a subscription of US$ 500,000 in GALY CO ("GALY") in the form of a SAFE. GALY is a Boston, USA, based pioneering biomaterials technology company, producing cotton grown in a lab.
On 31 Mar ch 2020, the Company completed a subscription of US$ 2,999,996 in Tropic Biosciences UK Limited ("Tropic"). Tropic is a leading biotechnology company based in Norwich, UK, which is utilising powerful gene-editing techniques including CRISPR-Cas9 and Tropic's own proprietary GEiGS(TM) platform in developing high-performing commercial varieties of tropical crops.
Your board continues to evaluate a number of opportunities which show significant growth prospects".
Unaudited to 31 March 2020 GBP Fixed Assets Investments 14,470,478 Current Assets Uninvested cash 3,890,306 Sundry Debtors 38,055 Current Liabilities Trade and other creditors (66,242) ------------------ 18,332,597 Capital and Reserves Share Capital 23 Share Premium 19,578,859 Reserves (1,246,285) ------------------ 18,332,597 Shares in Issue 331,616,661 Net Asset Value per share 5.53 pence
Portfolio Details
Investments as at 31 March Value (GBP) % of Total Portfolio 2020 AgeX Therapeutics Inc 89,914 0.62% Regent Pacific Group Limited 83,760 0.58% Portage Biotech Inc 215,524 1.49% Other quoted holdings 14,972 0.10% Other unquoted holdings 14,066,308 97.21% Total 14,470,478 100.00%
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ('MAR'). Upon the publication of this announcement via a Regulatory Information Service ('RIS'), this inside information is now considered to be in the public domain.
For further information, please contact:
Agronomics Limited Beaumont Zeus Capital Peterhouse Britton Financial Cornish Limited Capital Limited PR Limited The Company Nomad Joint Broker Joint Broker Investor Relations --------------------- ------------------- ----------------- ------------------ Denham Eke Roland Cornish/James Mike Seabrook/ Lucy Williams Tim Blackstone +44 (0) 1624 639396 Biddle Rupert Woolfenden +44 (0) 207 +44 (0)7957 +44 (0) +44 (0) 161 469 0936 140416 207 628 393 1975 3396 --------------------- ------------------- ----------------- ------------------
ENDS
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
NAVKKNBKOBKDPQD
(END) Dow Jones Newswires
April 14, 2020 02:00 ET (06:00 GMT)
1 Year Agronomics Chart |
1 Month Agronomics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions